Company Overview
About Cytovale
Cytovale is a medical technology company headquartered in San Francisco, California, founded in 2014 by Lydia Sohn and others, with roots in biophysics research at the University of California, Berkeley. The company is developing the IntelliSep test — a rapid, near-patient diagnostic for sepsis that uses a proprietary microfluidic technology to measure the mechanical properties (deformability) of immune cells in whole blood. Sepsis — a life-threatening systemic immune response to infection — kills approximately 270,000 Americans annually and is the leading cause of hospital mortality, yet current diagnostic approaches (blood cultures, lactate, clinical scoring systems) are slow, non-specific, and frequently fail to identify sepsis before it progresses to organ failure and septic shock.
Business Model & Competitive Advantage
IntelliSep works by flowing a small whole blood sample through a microfluidic chip where neutrophils (key immune cells) are squeezed through defined constrictions. Sepsis causes measurable changes in neutrophil cell mechanics — septic neutrophils become more deformable (softer) than healthy neutrophils due to cytoskeletal changes driven by sepsis pathophysiology. Cytovale's system measures these biophysical changes to generate an IntelliSep Index score within approximately 8 minutes at the point of care, providing emergency physicians with an objective sepsis likelihood score to guide early treatment decisions. The test has received FDA Breakthrough Device Designation, reflecting the agency's assessment that it addresses an unmet medical need.
Competitive Landscape 2025–2026
Cytovale raised $88M in total funding across multiple rounds, with investors including Khosla Ventures, Greycroft, Triventures, and other healthcare and life sciences investors. The company competes in the sepsis diagnostics market against Inflammatix (host-gene expression sepsis test), BioMérieux (blood culture and procalcitonin testing), and clinical AI decision support tools. Cytovale's differentiation is the speed (8-minute turnaround versus 24–72 hours for blood culture), the non-culture-based mechanism, and the point-of-care deployment model suitable for emergency department workflows.
Key Differentiators
Emerging Innovator
Cytovale is an emerging player bringing innovative solutions to the Healthcare market.
Frequently Asked Questions
Similar Brands
Oracle Health
Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, reve
athenahealth
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on
CoverMyMeds
CoverMyMeds is the largest prior authorization platform in the United States, operating a network that connects more than 750,000 providers, 75,000 pharmacies, and virtually all payers to streamline t
Abridge
Abridge is a Pittsburgh, Pennsylvania-based healthcare AI clinical documentation platform — backed with approximately $800 million in total funding including a $300 million Series E in June 2025 led b
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Idexx Laboratories
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu
Compare Cytovale with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Cytovale? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Cytovale Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Cytovale vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →